171 related articles for article (PubMed ID: 23208884)
1. Leprosy and tuberculosis co-infection: clinical and immunological report of two cases and review of the literature.
Trindade MÂ; Miyamoto D; Benard G; Sakai-Valente NY; Vasconcelos Dde M; Naafs B
Am J Trop Med Hyg; 2013 Feb; 88(2):236-40. PubMed ID: 23208884
[TBL] [Abstract][Full Text] [Related]
2. T-cell responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 in Brazilian tuberculosis patients.
Cardoso FL; Antas PR; Milagres AS; Geluk A; Franken KL; Oliveira EB; Teixeira HC; Nogueira SA; Sarno EN; Klatser P; Ottenhoff TH; Sampaio EP
Infect Immun; 2002 Dec; 70(12):6707-14. PubMed ID: 12438345
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis.
García-Rodríguez JF; Valcarce-Pardeiro N; Álvarez-Díaz H; Mariño-Callejo A
Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2121-2126. PubMed ID: 31377953
[TBL] [Abstract][Full Text] [Related]
4. Co-existence of mycobacterial infections: is it an emerging issue with retroviral infections?
Keragala B; Herath H; Janappriya G; Gunasekera CN
Trop Doct; 2019 Apr; 49(2):145-146. PubMed ID: 30582730
[TBL] [Abstract][Full Text] [Related]
5. The clinical recovery of tuberculosis patients undergoing specific treatment is associated with changes in the immune and neuroendocrine responses.
Díaz A; Bongiovanni B; D'Attilio L; Santucci N; Dídoli G; Fernández RDV; Kovalevski L; Lioi S; Gardeñez W; Brandan N; Nannini LJ; Besedovsky H; Del Rey A; Bottasso O; Bay ML
Pathog Dis; 2017 Sep; 75(7):. PubMed ID: 28854691
[TBL] [Abstract][Full Text] [Related]
6. Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts.
Schechter M; Zajdenverg R; Falco G; Barnes GL; Faulhaber JC; Coberly JS; Moore RD; Chaisson RE
Am J Respir Crit Care Med; 2006 Apr; 173(8):922-6. PubMed ID: 16474028
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendations.
Thee S; Seddon JA; Donald PR; Seifart HI; Werely CJ; Hesseling AC; Rosenkranz B; Roll S; Magdorf K; Schaaf HS
Antimicrob Agents Chemother; 2011 Dec; 55(12):5560-7. PubMed ID: 21968358
[TBL] [Abstract][Full Text] [Related]
9. A retrospective study on Xpert MTB/RIF for detection of tuberculosis in a teaching hospital in China.
Li S; Lin L; Zhang F; Zhao C; Meng H; Wang H
BMC Infect Dis; 2020 May; 20(1):362. PubMed ID: 32448123
[TBL] [Abstract][Full Text] [Related]
10. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
Ige OM; Bakare NA; Onadeko BO
Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
[TBL] [Abstract][Full Text] [Related]
11. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
12. A retrospective study on tuberculosis treatment outcomes at Jinka General Hospital, southern Ethiopia.
Wondale B; Medihn G; Teklu T; Mersha W; Tamirat M; Ameni G
BMC Res Notes; 2017 Dec; 10(1):680. PubMed ID: 29202880
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis.
Mzinza DT; Sloan DJ; Jambo KC; Shani D; Kamdolozi M; Wilkinson KA; Wilkinson RJ; Davies GR; Heyderman RS; Mwandumba HC
Tuberculosis (Edinb); 2015 Jul; 95(4):463-9. PubMed ID: 26051653
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis and Leprosy Coinfection: A Perspective on Diagnosis and Treatment.
Mangum L; Kilpatrick D; Stryjewska B; Sampath R
Open Forum Infect Dis; 2018 Jul; 5(7):ofy133. PubMed ID: 30046638
[TBL] [Abstract][Full Text] [Related]
15. Coinfection of leprosy and tuberculosis.
Shetty S; Umakanth S; Manandhar B; Nepali PB
BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29545426
[TBL] [Abstract][Full Text] [Related]
16. [Efficiency of shorter chemotherapy courses for intrathoracic tuberculosis in children].
Iukhimenko NV
Probl Tuberk; 2000; (3):20-3. PubMed ID: 10900978
[TBL] [Abstract][Full Text] [Related]
17. Isoniazid- and streptomycin-resistant miliary tuberculosis complicated by intracranial tuberculoma in a Japanese infant.
Ishiwada N; Tokunaga O; Nagasawa K; Ichimoto K; Kinoshita K; Hishiki H; Kohno Y
Tohoku J Exp Med; 2013 Mar; 229(3):221-5. PubMed ID: 23470647
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of the performances of MTD Gene-Probe® test, BACTEC 960™ system and Löwenstein-Jensen culture methods in the diagnosis of smear-negative tuberculosis cases].
Kunduracıoğlu A; Karasu I; Biçmen C; Ozsöz A; Erbaycu AE
Mikrobiyol Bul; 2013 Jul; 47(3):417-31. PubMed ID: 23971920
[TBL] [Abstract][Full Text] [Related]
19. IL-37 Expression is Upregulated in Patients with Tuberculosis and Induces Macrophages Towards an M2-like Phenotype.
Huang Z; Gao C; Chi X; Hu YW; Zheng L; Zeng T; Wang Q
Scand J Immunol; 2015 Oct; 82(4):370-9. PubMed ID: 26073153
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment Guidelines.
Bekker A; Schaaf HS; Draper HR; van der Laan L; Murray S; Wiesner L; Donald PR; McIlleron HM; Hesseling AC
Antimicrob Agents Chemother; 2016 Apr; 60(4):2171-9. PubMed ID: 26810651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
